Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …

Introduction Most psychiatric inpatients receive psychopharmacological treatment indicated
for their mental diseases. The aim of this systematic review is to give clinical pharmacists …

Aim: Drug-drug interaction (DDI) is of major concern in patients with complex therapeutic
regimens. The involvement of cardiovascular medicines in drug interaction is even higher …

“Any response to a drug which is noxious, unintended & which occurs at dose normally used
in man for the prophylaxis, diagnosis, or therapy of disease, or for the modifications of …

The majority of the antipsychotic drugs are also known to interact with other co-administered
drugs. Drug–drug interaction (DDI) reports among patients receiving antipsychotic …

Purpose: New pharmacovigilance methods are needed as a consequence of the morbidity
caused by drugs. We exploit fine-grained drug related adverse event information extracted …

Introduction: Potential drug-drug interactions (pDDIs) are very frequent in psychiatric
practice and result in poor tolerability or reduced efficacy, or both, which can negatively …

Introduction: A clinically relevant drug-drug occurs when the effectiveness or toxicity of one
medication is altered by the administration of another medicine. Potential Drug-drug …

Objective: To determine the prevalence of drug-related problems and the factors influencing
them among adult psychiatric inpatients. Methods: A multi-centre cross-sectional …

Background: Antipsychotics and mood stabilizers are associated with adverse effects which
can affect the compliance and course of treatment in mental disorders. The present study …